{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:02:37Z","timestamp":1768082557481,"version":"3.49.0"},"reference-count":36,"publisher":"American Society for Microbiology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Tuberculosis (TB) is a reemerging disease. The only available vaccine,<jats:named-content content-type=\"genus-species\">Mycobacterium bovis<\/jats:named-content>BCG, is delivered intradermally and confers highly variable efficacy against pulmonary disease. There is an urgent need for improved vaccination strategies. Murine studies suggest that immunizations delivered directly to the respiratory mucosa might be a more effective route of vaccination. This study compared the immunogenicity of a leading candidate tuberculosis (TB) vaccine, modified vaccinia virus Ankara expressing antigen 85A (MVA85A), in rhesus macaques, delivered either as an aerosol or as an intradermal boost immunization 12 weeks after an intradermal BCG prime vaccine. Aerosol vaccination was well tolerated. MVA85A delivered by aerosol or by intradermal injection induced antigen-specific immune responses in the periphery and the lung, with a trend toward the highest response when the compartment and route of delivery were matched. The ability of poxvirus-vectored vaccines delivered by the systemic route to induce responses in the mucosal immune compartment in macaques is in contrast to the independent compartmentalization of mucosal and systemic immune systems described in mice. Unlike intradermal vaccination, aerosol vaccination did not induce a detectable serum anti-vector antibody response. The delivery of vaccines to the lungs might provide an immunization strategy that limits the induction of systemic anti-vector immunity, which would be extremely useful in the development of improved vaccine strategies. This is the first study to show a recombinant MVA-vectored vaccine to be highly immunogenic when delivered by the aerosol route to nonhuman primates. These results provide important safety and proof-of-concept data for further evaluation of this route of immunization for use in human clinical trials.<\/jats:p>","DOI":"10.1128\/cvi.00690-12","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T18:12:16Z","timestamp":1362075136000},"page":"663-672","source":"Crossref","is-referenced-by-count":78,"title":["Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques"],"prefix":"10.1128","volume":"20","author":[{"given":"A. D.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Reyes-Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. W.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"key20180919073650_B1","volume-title":"Global tuberculosis report 2012","author":"World Health Organization","year":"2012"},{"key":"key20180919073650_B2","first-page":"698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis","volume":"271","author":"Colditz","year":"1994","journal-title":"Meta-analysis of the published literature. JAMA"},{"key":"key20180919073650_B3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"key20180919073650_B4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Abstammung eigenschaften und verwendung des attenuierten vaccinia-stammes MVA","volume":"105","author":"Mayr","year":"1975","journal-title":"Infection"},{"key":"key20180919073650_B5","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073650_B6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"key":"key20180919073650_B7","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0264-410X(94)90341-7","article-title":"A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus","volume":"12","author":"Sutter","year":"1994","journal-title":"Vaccine"},{"key":"key20180919073650_B8","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.70.6.3741-3752.1996","article-title":"Patterns of virus replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia Ankara","volume":"70","author":"Hirsch","year":"1996","journal-title":"J. Virol."},{"key":"key20180919073650_B9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4+ T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073650_B10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb.)"},{"key":"key20180919073650_B11","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS One"},{"key":"key20180919073650_B12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/CVI.00229-09","article-title":"Adjuvants induce distinct immunological phenotypes in a cattle tuberculosis vaccine model","volume":"16","author":"Vordermeier","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073650_B13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J. Immunol."},{"key":"key20180919073650_B14","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J. Immunol."},{"key":"key20180919073650_B15","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1073\/pnas.93.6.2272","article-title":"gamma\/delta and other unconventional T lymphocytes: what do they see and what do they do","volume":"93","author":"Kaufmann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073650_B16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"key20180919073650_B17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tube.2008.06.005","article-title":"A comparison of IFNgamma detection methods used in tuberculosis vaccine trials","volume":"88","author":"Beveridge","year":"2008","journal-title":"Tuberculosis (Edinb.)"},{"key":"key20180919073650_B18","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J. Exp. Med."},{"key":"key20180919073650_B19","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1172\/JCI119810","article-title":"Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Gu\u00e9rin infection and a sibling with clinical tuberculosis","volume":"100","author":"Jouanguy","year":"1997","journal-title":"J. Clin. Invest."},{"key":"key20180919073650_B20","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.4049\/jimmunol.160.9.4490","article-title":"Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes","volume":"160","author":"Bonecini-Almeida","year":"1998","journal-title":"J. Immunol."},{"key":"key20180919073650_B21","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"key20180919073650_B22","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection","volume":"71","author":"Capuano","year":"2003","journal-title":"Infect. Immun."},{"key":"key20180919073650_B23","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/313885","article-title":"A nonhuman primate model for the preclinical testing of new tuberculosis vaccines","volume":"30","author":"McMurray","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073650_B24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/IAI.2.5.574-582.1970","article-title":"Aerosol-induced tuberculosis in sub-human primates and the course of the disease after intravenous BCG vaccination","volume":"2","author":"Barclay","year":"1970","journal-title":"Infect. Immun."},{"key":"key20180919073650_B25","first-page":"351","article-title":"Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin","volume":"107","author":"Barclay","year":"1973","journal-title":"Am. Rev. Respir. Dis."},{"key":"key20180919073650_B26","first-page":"43","article-title":"Tuberculin-induced lymphocyte transformation and skin reactivity in monkeys vaccinated or not vaccinated with Bacille Calmette-Guerin, then challenged with virulent Mycobacterium tuberculosis","volume":"112","author":"Chaparas","year":"1975","journal-title":"Am. Rev. Respir. Dis."},{"key":"key20180919073650_B27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1749-6632.1968.tb16710.x","article-title":"Simian tuberculosis: immunologic aspects","volume":"154","author":"Good","year":"1968","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"key20180919073650_B28","first-page":"359","article-title":"Immune responses in rhesus monkeys after bacille Calmette-Guerin vaccination and aerosol challenge with Mycobacterium tuberculosis","volume":"107","author":"Janicki","year":"1973","journal-title":"Am. Rev. Respir. Dis."},{"key":"key20180919073650_B29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00079-10","article-title":"Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing","volume":"17","author":"Sharpe","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073650_B30","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0705191105","article-title":"Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic","volume":"105","author":"Corbett","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073650_B31","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1073\/pnas.96.8.4512","article-title":"Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity","volume":"96","author":"Belyakov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073650_B32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2009.130","article-title":"New insights on adenovirus as vaccine vectors","volume":"17","author":"Lasaro","year":"2009","journal-title":"Mol. Ther."},{"key":"key20180919073650_B33","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors","volume":"81","author":"McCoy","year":"2007","journal-title":"J. Virol."},{"key":"key20180919073650_B34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat. Med."},{"key":"key20180919073650_B35","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1099\/0022-1317-82-9-2215","article-title":"Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity","volume":"82","author":"Sharpe","year":"2001","journal-title":"J. Gen. Virol."},{"key":"key20180919073650_B36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.vaccine.2007.11.010","article-title":"Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis","volume":"26","author":"Low","year":"2008","journal-title":"Vaccine"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00690-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T20:28:00Z","timestamp":1688070480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00690-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,4,26]]},"published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1128\/CVI.00690-12"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00690-12","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]}}}